These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15879443)

  • 1. Cost-effectiveness of integrated stroke services.
    van Exel NJ; Koopmanschap MA; Scholte op Reimer W; Niessen LW; Huijsman R
    QJM; 2005 Jun; 98(6):415-25. PubMed ID: 15879443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost effectiveness of combined spa-exercise therapy in ankylosing spondylitis: a randomized controlled trial.
    Van Tubergen A; Boonen A; Landewé R; Rutten-Van Mölken M; Van Der Heijde D; Hidding A; Van Der Linden S
    Arthritis Rheum; 2002 Oct; 47(5):459-67. PubMed ID: 12382292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cost evaluation of a model for integrated care of seriously mentally ill patients].
    Fischer F; Hoffmann K; Mönter N; Walle M; Beneke R; Negenborn S; Weinmann S; Willich SN; Berghöfer A
    Gesundheitswesen; 2014 Feb; 76(2):86-95. PubMed ID: 23737155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The social and economic burden of stroke survivors in Italy: a prospective, incidence-based, multi-centre cost of illness study.
    Fattore G; Torbica A; Susi A; Giovanni A; Benelli G; Gozzo M; Toso V
    BMC Neurol; 2012 Nov; 12():137. PubMed ID: 23150894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic evaluation alongside a phase II, multi-centre, randomised controlled trial of very early rehabilitation after stroke (AVERT).
    Tay-Teo K; Moodie M; Bernhardt J; Thrift AG; Collier J; Donnan G; Dewey H
    Cerebrovasc Dis; 2008; 26(5):475-81. PubMed ID: 18810233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative strategies for stroke care: cost-effectiveness and cost-utility analyses from a prospective randomized controlled trial.
    Patel A; Knapp M; Perez I; Evans A; Kalra L
    Stroke; 2004 Jan; 35(1):196-203. PubMed ID: 14684783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Future costs of stroke in the Netherlands: the impact of stroke services.
    Struijs JN; van Genugten ML; Evers SM; Ament AJ; Baan CA; van den Bos GA
    Int J Technol Assess Health Care; 2006; 22(4):518-24. PubMed ID: 16984687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How has the impact of 'care pathway technologies' on service integration in stroke care been measured and what is the strength of the evidence to support their effectiveness in this respect?
    Allen D; Rixson L
    Int J Evid Based Healthc; 2008 Mar; 6(1):78-110. PubMed ID: 21631815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The incremental cost effectiveness of in-patient versus out-patient rehabilitation after total hip arthroplasty - results of a pilot investigation.
    Krummenauer F; Günther KP; Witzlebf WC
    Eur J Med Res; 2008 Jun; 13(6):267-74. PubMed ID: 18558552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluation of an integrated care programme for patients with hand dermatitis.
    van Gils RF; Bosmans JE; Boot CR; Rustemeyer T; van Mechelen W; van der Valk PG; Anema JR
    Contact Dermatitis; 2013 Sep; 69(3):144-52. PubMed ID: 23808896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An economic evaluation of budesonide/formoterol for maintenance and reliever treatment in asthma in general practice.
    Goossens LM; Riemersma RA; Postma DS; van der Molen T; Rutten-van Mölken MP
    Adv Ther; 2009 Sep; 26(9):872-85. PubMed ID: 19768640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early supported discharge for stroke patients improves clinical outcome. Does it also reduce use of health services and costs? One-year follow-up of a randomized controlled trial.
    Fjaertoft H; Indredavik B; Magnussen J; Johnsen R
    Cerebrovasc Dis; 2005; 19(6):376-83. PubMed ID: 15860914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs and quality of life in multiple sclerosis in The Netherlands.
    Kobelt G; Berg J; Lindgren P; Anten B; Ekman M; Jongen PJ; Polman C; Uitdehaag B
    Eur J Health Econ; 2006 Sep; 7 Suppl 2():S55-64. PubMed ID: 17310343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is integrated nursing home care cheaper than traditional care? A cost comparison.
    Paulus AT; van Raak AJ; Maarse HJ
    Int J Nurs Stud; 2008 Dec; 45(12):1764-77. PubMed ID: 18755460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of Australian stroke services: a prospective, multicenter study comparing dedicated stroke units with other care modalities.
    Moodie M; Cadilhac D; Pearce D; Mihalopoulos C; Carter R; Davis S; Donnan G;
    Stroke; 2006 Nov; 37(11):2790-5. PubMed ID: 17008615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home-based cardiac rehabilitation versus hospital-based rehabilitation: a cost effectiveness analysis.
    Taylor RS; Watt A; Dalal HM; Evans PH; Campbell JL; Read KL; Mourant AJ; Wingham J; Thompson DR; Pereira Gray DJ
    Int J Cardiol; 2007 Jul; 119(2):196-201. PubMed ID: 17084927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total direct cost, length of hospital stay, institutional discharges and their determinants from rehabilitation settings in stroke patients.
    Saxena SK; Ng TP; Yong D; Fong NP; Gerald K
    Acta Neurol Scand; 2006 Nov; 114(5):307-14. PubMed ID: 17022777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of conventional and endovascular repair of abdominal aortic aneurysms: results of a randomized trial.
    Prinssen M; Buskens E; de Jong SE; Buth J; Mackaay AJ; van Sambeek MR; Blankensteijn JD;
    J Vasc Surg; 2007 Nov; 46(5):883-890. PubMed ID: 17980274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.